article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. In classic Amazon style, its pharmacy offers two-day shipping on prescriptions by mail, with same-day delivery available in seven markets, with plans to add a dozen more cities by year end.

Retail 52
article thumbnail

Consequences of the First 10 Drugs Selected for Medicare’s Negotiation Program

PM360

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. CMS will present an initial offer for each drug’s maximum fair price (MFP) by February 1, 2024.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Relief for Amylyx as FDA clears controversial ALS drug Relyvrio

pharmaphorum

In March, the first advisory committee agreed with the opinion voiced by the FDA reviewer that there were doubts about the efficacy of Relyvrio, and that it would be preferable to wait for the results of an ongoing, larger study – now expected to read out in 2024.

FDA 81
article thumbnail

Two Key Questions About Payer Strategies in 2023

PM360

This is especially significant for manufacturers of high-cost specialty drugs, who will now face a recurring additional 20% charge on virtually every prescription fill. On the other side, drug manufacturers are facing the squeeze, with caps on price inflation and a mandated 20% discount in the catastrophic phase.

article thumbnail

Your 2024 Legal Vision Board: Trends and Opportunities for Digital Health Innovators

Nixon Gwilt Law

What can digital health innovators and investors anticipate for the industry in 2024? What can digital health innovators and investors anticipate for the industry in 2024? Read on to find out what else is on our Legal Vision Board for 2024! How is 2024 Shaping up for Your Business?

article thumbnail

8 Tactics to Increase HCP Engagement in 2024

PM360

A significant battle for the hearts and minds of healthcare professionals (HCPs) will play out in social media during 2024. Fifty percent of responders said they changed prescriptions because of social media information. Expect the demand for MSLs to assist the promotional side of the business to continue and expand.

Media 122
article thumbnail

Humira biosimilars set the stage for long-awaited 2023 US launches

Pharmaceutical Technology

Biosimilars with this designation are beneficial to payers as they eliminate the need for another prescription, she explains An interchangeable biosimilar can be automatically substituted for Humira at a pharmacy, Bhat adds. Samsung Bioepis and Organon previously stated that Hadlima's interchangeability data should be ready in 2024.

Marketing 104